Cannabis Science, Inc.
(Other OTC/NBB : CBIS)

( )
CBIS PreMarket: $ () as of AM
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield

Message Boards

...

News

...
Health Technology » Biotechnology

Company Profile

Cannabis Science, Inc. develops cannabis pharmaceutical products. It is at the forefront of cannabinoid research and development. The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products. It is laying a solid foundation for entrance into the FDA and other government regulatory agencies for developing medicines for cancer, autism, Influenza, PTSD and other ailments. Cannabis Science was founded on February 29, 1996 and is headquartered in Colorado Springs, CO.